AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Therapeutic vaccines firm raises UKP15 million in international funding round.
2003 MAY 14 - (NewsRx.com & NewsRx.net) -- Oxxon Pharmaccines Ltd., a biotechnology company developing innovative immunotherapeutics, specifically therapeutic vaccines (pharmaccines), has raised UKP15 million pounds ($23 million) in a private financing round.
The funds will drive Oxxon's therapeutic vaccine clinical programs in the areas of chronic infectious diseases and cancer.
An international syndicate of investors was led by Quester Capital Management (UK) and included Isis Capital (UK), NIF Ventures (Japan), Gray Ghost, LLC (US), and an institutional investor (US). Existing shareholders MVM (UK), Neomed Innovation ASA (Norway), and The Isis College Fund (UK) also committed further funds.
Dr. Deirdre Gillespie, Oxxon, said, "I am delighted to announce the completion of this financing round. We are now focused on driving our two therapeutic vaccine products to proof of clinical efficacy, and on broadening our pipeline. The funds will provide the resources necessary to achieve these milestones and to ...
- UK Biotechnology company Oxxon Pharmaccines has formed a Scientific Advisory...
- Magazine article from: Chemistry and Industry December 16, 2002 700+ words
UK Biotechnology company Oxxon Pharmaccines has formed a Scientific Advisory Board (SAB). The board will be chaired by Adrian Hill, a Wellcome Trust principal research...
- Oxxon Pharmaccines(TM) Raises 15 Million Pounds Sterling In International...
- Press release article from: PR Newswire April 14, 2003 700+ words
...14 /PRNewswire/ -- Oxxon Pharmaccines Ltd (Oxxon), a biotechnology...Capital Management (UK) and included Isis...Existing shareholders MVM (UK), Neomed Innovation...Isis College Fund (UK) also committed further...commercial capabilities." Oxxon Pharmaccines is a ...
- Oxxon Pharmaccines(TM) Melanoma Therapeutic Vaccine Enters Phase II Clinical...
- Press release article from: PR Newswire October 14, 2002 700+ words
...OXFORD, England -- Oxxon Pharmaccines Ltd (Oxxon), a...clinical trials in the UK. The Phase I clinical...Each year in the UK around 5,500 people...Notes to Editors Oxxon Pharmaccines Oxxon Pharmaccines is a biotechnology...
- Oxxon Pharmaccines names Frank Malinoski as CMO.(Brief Article)
- Newspaper article from: Pharma Marketletter March 15, 2004 700+ words
Frank Malinoski has joined UK-based biotechnology company Oxxon Pharmaccines as chief medical officer. His previous appointment was that of vice president of global business development at Wyeth Vaccines.
- Oxxon Pharmaccines.(Movers & Shakers)(Brief Article)
- Magazine article from: Chemistry and Industry April 5, 2004 700+ words
Oxxon Pharmaccines (Oxxon) has announced the appointment of Frank Malinoski as executive...experience in vaccine and immunotherapeutic development to Oxxon. Oxxon is a UK biotechnology company developing immunotherapeutics for cancer and chronic...
- New name and US unit for Oxxon.(Oxxon Pharmaccines )(Oxxon Therapeutics)(Brief...
- Newspaper article from: Pharma Marketletter April 19, 2004 700+ words
UK biotechnology firm Oxxon Pharmaccines has changed its name to Oxxon Therapeutics. At the same time...well as administration, will continue to be run from Oxxon's UK base in Oxford. Oxxon is a mid-stage company developing a portfolio...
- Oxxon Launches U.S. Operation and Announces New Name; UK therapeutic vaccine...
- Press release article from: PR Newswire April 13, 2004 700+ words
...Oxxon Therapeutics Ltd (formerly Oxxon Pharmaccines), a biotechnology company developing...from the company's base in Oxford, UK. Oxxon Therapeutics(TM) is a mid...com, both of De Facto Communications, UK, +44-20-7496-3300, for Oxxon...
- OTHER NEWS TO NOTE.
- Magazine article from: BIOWORLD Today January 3, 2001 700+ words
...Oxford Biomedica plc, of Oxford, UK, said the Medicines Control Agency, the UK's National Health Service regulatory...Peter Johnson nonexecutive chairman. Oxxon Pharmaccines Ltd., of Oxford, UK, closed a [pound]4.7 million...
Source: HighBeam Research, Therapeutic vaccines firm raises UKP15 million in international...